FDA under probe over power morcellators’ cancer risk
Twelve lawmakers have asked a government watchdog agency to inquire further as to why the U.S. Food and Drug Administration (FDA) took a long time to warn about power morcellators‘ risk of spreading undetected uterine cancer, Medscape reported on Tuesday, August 11.
In a letter addressed to the U.S. Government Accountability Office (GAO), the members of Congress requested a study about the FDA’s delayed response over the medical device’s cancer risk. Lawmakers also asked the GAO to investigate whether the FDA’s current process of approving medical devices was enough to detect the dangers posed by the device.
In April 2014, the FDA advised surgeons to stop using power morcellators for uterine fibroid removal after learning that 1 in 350 women with benign uterine masses have undetected uterine cancer.
If your health has been compromised after undergoing a laparoscopic procedure involving a power morcellator, our team of power morcellator attorneys at Williams Kherkher might be able to help you secure the compensation you believe you deserve from the device manufacturer involved. Call us at (800) 220-9341 and tell us more about your situation.